Omada Health, Inc. (NASDAQ:OMDA) Receives $25.00 Average PT from Brokerages

Shares of Omada Health, Inc. (NASDAQ:OMDA) have earned a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have given a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $25.00.

OMDA has been the topic of several recent analyst reports. Robert W. Baird initiated coverage on shares of Omada Health in a report on Friday, September 5th. They set a “neutral” rating and a $24.00 price objective on the stock. Needham & Company LLC increased their price objective on shares of Omada Health from $23.00 to $24.00 and gave the company a “buy” rating in a report on Friday, August 8th. Baird R W raised shares of Omada Health to a “hold” rating in a report on Friday, September 5th. Wall Street Zen raised shares of Omada Health to a “hold” rating in a report on Monday, June 16th. Finally, Morgan Stanley initiated coverage on shares of Omada Health in a report on Tuesday, July 1st. They set an “overweight” rating and a $25.00 price objective on the stock.

Omada Health Trading Down 0.0%

Shares of NASDAQ OMDA opened at $24.00 on Thursday. The business’s fifty day moving average price is $22.17. Omada Health has a 1 year low of $14.14 and a 1 year high of $28.40.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, August 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.07). The company had revenue of $61.37 million for the quarter, compared to analysts’ expectations of $55.17 million. Omada Health has set its FY 2025 guidance at EPS.

Hedge Funds Weigh In On Omada Health

Several hedge funds and other institutional investors have recently modified their holdings of OMDA. Perceptive Advisors LLC purchased a new position in shares of Omada Health in the second quarter worth about $44,402,000. Loomis Sayles & Co. L P purchased a new position in shares of Omada Health in the second quarter worth about $19,948,000. Sanofi purchased a new position in shares of Omada Health in the second quarter worth about $9,606,000. Federated Hermes Inc. purchased a new position in shares of Omada Health in the second quarter worth about $9,150,000. Finally, Norges Bank purchased a new position in shares of Omada Health in the second quarter worth about $5,490,000.

Omada Health Company Profile

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.